Private Equity: The Nature of the Beast - Event Write-up


Private equity money has backed some of the largest and most audacious M&A deals of the past decade, but now that the flow of credit has slowed to a trickle and covenants are tightening, the days of blockbusting management buy-outs (MBOs) are over. Nevertheless, $23.1 billion was raised by UK funds in 2008; there is still plenty of activity in the mid-market, and distressed assets may present some good-value acquisition opportunities. Criticaleye Members convened at this Discussion Group chaired by Simmons and Simmons' Arthur Stewart to build this guide to private equity, and establish how to navigate through the belly of the beast.

Share this with your Community



Contributor
Arthur Stewart
Partner
Simmons & Simmons


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

VIEWPOINTS | International Expansion in a Nutshell

Once a business has reached maturity in its home market, attention naturally turns to international expansion as the next growth frontier.   Nick Burns has first-hand experience of this during his time as ...


Inspiring Leaders Podcast: Building Beyond Borders – Leadership and Expansion Strategy (ft. Nick Burns)

Nick Burns, CEO of Reward Gateway | Edenred, joins Criticaleye’s Senior Editor Bridgette Hall to share his perspective on what it takes to deliver successful international expansion in today’s complex bus...


Click here to download this insight

BLOG | Alignment at the Top

At our recent Growth Company Retreat, one theme came through consistently across discussions with executives and non-executive directors of high growth business leaders: strategy alone is not enough, alignme...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 36




NATS AlixPartners Mayborn Group Worldpay Legal & General Lightsource bp NatWest Group CrowdStrike E.ON UK Aldermore Group London Stock Exchange Group Rolls-Royce Drax Group plc Stream Canaccord Genuity Group Inc GlaxoSmithKline plc Hitachi Solutions LACE Partners British Land